该站点未添加描述description...

山东胜晔磨球有限公司专业生产棒磨机钢棒与耐磨钢棒、锻造球磨机钢球的生产厂家。研发的新型棒磨机耐磨钢棒使用全自动的耐磨钢棒自动设备，独特高压急速贝氏体化淬火热处理，整条圆钢一次性均匀加热，生产出来的棒磨机钢棒回火马氏体与贝氏体结合，耐磨性能提升且不断棒。耐磨钢球使用全自动化生产设备轧制/锻造而成，整体圆钢使用电炉均匀加热，确保生产锻造钢球硬件均匀且不破碎。

该站点未添加描述description...

该站点未添加描述description...

该站点未添加描述description...

广东宏荣环境科技有限公司坐落于惠州市仲恺高新开发区，是一家集研发、咨询、设计、设备制造、工程建设、系统运营以及环保管家综合服务（环评审批、验收监测、环保验收、环保排污许可证及环境突发事件应急预案、“一企一策”、清洁生产等服务）于一体的综合性环保服务企业。 公司成立于2012年，前身为惠州节能环保公司，因业务升级，为了更好的服务客户，现变更为广东宏荣环境科技有限公司。公司由十几年环保经验的资深工程师和技术人员组成的集水处理、废气（VOCs）处理、粉尘处理、噪声处理等环保设备制作、工程设计、工程安装等于一体的专业环保技术团队，能够对各种环境污染项目进行完善的分析、研究、设计、治理。

该站点未添加描述description...

WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.

汇华财务专注于为中小企业提供包括代理记账、工商注册、工商变更、审计、商标代理、知识产权代理等专业高效的一体化知识产权＋财税服务。

徐州丰彩纺织科技股份有限公司（徐州丰彩针织有限公司）坐落于两汉文化发源地、被誉为“中国天鹅绒之冠“的古彭徐州。工厂位于徐州市棠张工业园区，占地20亩，员工100余人，年生产能力2000吨。